Revenue was above guidance, but the standout was the margin jump in 2H23 as several projects completed. The balance sheet is healthy, with $86M cash despite $31M paid in dividends through the year. Visibility for the next couple of years is good and will get better when formal go-ahead is received on two near-term opportunities.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.